- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04097236
Body Position and Ultrasound Examination of the Gastric Antrum (POSIGAST)
August 26, 2025 updated by: Hospices Civils de Lyon
Diagnostic Performance of the Ultrasound Examination of the Antrum to Detect a Full Stomach According to the Position of the Patient
Pulmonary aspiration of gastric contents is a complication causing significant morbidity and mortality related to anesthesia.
Ultrasound examination of the gastric antrum allows the detection of preoperative gastric contents contributing to the preoperative assessment of pulmonary aspiration risk.
In particular, this examination is based on the qualitative analysis of gastric contents performed in the supine and in the right lateral decubitus, using a qualitative score which makes it possible to discriminate a low liquid content of a large liquid volume.
This score has been described in patients and volunteers installed on a bed without elevation of the upper section of the bed.
However, in several studies, this qualitative score has been achieved in the 45° semirecumbent position, which may have affected the diagnostic performance of the examination thus performed, as suggested by the results of a study recently conducted by the investigating team.
This study therefore aims to compare the diagnostic performance of the qualitative analysis of the gastric antrum performed in the supine and the right lateral decubitus for the diagnosis of gastric volumes higher than 50 ml and 100 ml, according to the bed angle: 45 ° elevation or no elevation of the upper section of the bed.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
21
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bron, France, 69500
- Hospices Civils de Lyon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults 18 years old or older
- Last consumption of solids at least 6 hours before the start of the study, last consumption of clear fluids at least 2 hours before the start of the study
- Informed consent must have been signed.
- No significant medical history (American Society of Anesthesiologists (ASA) class 1)
Exclusion Criteria:
- Adult unable to give informed consent
- Previous gastrointestinal surgery
- Medication affecting gastric motility
- Digestive diseases, gastroparesis, diabetes mellitus with insulin
- Pregnancy or breastfeeding
- Obesity (Body Mass Index (BMI) ≥ 30 kilograms/meter² (kg/m²))
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: 45° semirecumbent position
|
Ultrasound examination of the gastric antrum are performed 3 minutes after the ingestion of a volume of water (either 0, 50, 100, 150, or 200 milliliters (ml), determined by randomization).
The procedure is repeated three times (three different volumes, the same volumes for each session with randomized order for each session).
|
|
Active Comparator: No elevation of the upper section of the bed
|
Ultrasound examination of the gastric antrum are performed 3 minutes after the ingestion of a volume of water (either 0, 50, 100, 150, or 200 milliliters (ml), determined by randomization).
The procedure is repeated three times (three different volumes, the same volumes for each session with randomized order for each session).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calculation of the sensitivity
Time Frame: 3 minutes
|
Diagnostic performance of the qualitative examination of the gastric antrum in the 45° semirecumbent position.
|
3 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Calculation of the specificity
Time Frame: 3 minutes
|
Diagnostic performance of the qualitative examination of the gastric antrum in full supine/right lateral decubitus position. The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers. |
3 minutes
|
|
Calculation of the positive predictive value,
Time Frame: 3 minutes
|
Diagnostic performance of the qualitative examination of the gastric antrum in full supine/right lateral decubitus position.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers.
|
3 minutes
|
|
Calculation of the negative predictive value
Time Frame: 3 minutes
|
Diagnostic performance of the qualitative examination of the gastric antrum in full supine/right lateral decubitus position.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers.
|
3 minutes
|
|
Calculation of the positive and negative likelihood ratio.
Time Frame: 3 minutes
|
Diagnostic performance of the qualitative examination of the gastric antrum in full supine/right lateral decubitus position.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers.
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position
Time Frame: 3 minutes
|
Calculation of the sensitivity.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position
Time Frame: 3 minutes
|
Calculation of the specificity The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position
Time Frame: 3 minutes
|
Calculation of the positive predictive value negative The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position
Time Frame: 3 minutes
|
Calculation of the negative predictive value.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum for the detection of gastric fluid volume ≥ 0.8 milliliters/kilogram (ml/kg) in the full supine and right lateral decubitus position and in the 45° semirecumbent position
Time Frame: 3 minutes
|
Calculation of the positive and negative likelihood ratio.
The diagnostic performance will be calculated according to the results of the qualitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Cut-off value for antral area measured in the supine position (semirecumbent or full supine position) associated with the best diagnostic performance for the detection of a gastric volume ≥1.5 milliliters/kilogram (ml/kg).
Time Frame: 3 minutes
|
The cut-off value will be calculated according to the results of the measurements performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum in the semirecumbent position without bed elevation
Time Frame: 3 minutes
|
Calculation of the sensitivity.
The diagnostic performance will be calculated according to the results of the qualitative and quantitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum in the semirecumbent position without bed elevation
Time Frame: 3 minutes
|
Calculation of the specificity.
The diagnostic performance will be calculated according to the results of the qualitative and quantitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum in the semirecumbent position without bed elevation
Time Frame: 3 minutes
|
Calculation of the positive predictive value.
The diagnostic performance will be calculated according to the results of the qualitative and quantitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum in the semirecumbent position without bed elevation
Time Frame: 3 minutes
|
Calculation of the negative predictive value.
The diagnostic performance will be calculated according to the results of the qualitative and quantitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Diagnostic performance of the qualitative examination of the gastric antrum in the semirecumbent position without bed elevation
Time Frame: 3 minutes
|
Calculation of the positive and negative likelihood ratio.
The diagnostic performance will be calculated according to the results of the qualitative and quantitative assessments performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
|
Mathematical model for the calculation of the gastric fluid volume
Time Frame: 3 minutes
|
Multiple linear regression including the antral surface measured in right lateral decubitus and the age, height, weight of the volunteer.
The mathematical model will be built according to the results of the measurements performed 3 minutes after the ingestion of water (either 0, 50, 100, 150 or 200 milliliters (ml)) by the volunteers
|
3 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sophie Barnoud, Dr, Hospices Civils de Lyon
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 27, 2019
Primary Completion (Actual)
September 6, 2021
Study Completion (Actual)
September 6, 2021
Study Registration Dates
First Submitted
May 15, 2019
First Submitted That Met QC Criteria
September 19, 2019
First Posted (Actual)
September 20, 2019
Study Record Updates
Last Update Posted (Estimated)
September 3, 2025
Last Update Submitted That Met QC Criteria
August 26, 2025
Last Verified
August 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Respiratory Tract Diseases
- Digestive System Diseases
- Gastrointestinal Diseases
- Respiration Disorders
- Esophageal Diseases
- Esophageal Motility Disorders
- Deglutition Disorders
- Laryngopharyngeal Reflux
- Gastroesophageal Reflux
- Respiratory Aspiration
- Pathological Conditions, Signs and Symptoms
- Respiratory Aspiration of Gastric Contents
Other Study ID Numbers
- 69HCL19_0244
- 2019-A01333-54 (Other Identifier: ID-RCB)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pulmonary Aspiration of Gastric Contents
-
St Vincent's Hospital MelbourneRecruitingPulmonary Aspiration of Gastric Contents | Residual Gastric ContentsAustralia
-
University Hospital, GenevaCompletedGastric Emptying | Aspiration of Gastric ContentsSwitzerland
-
Uppsala UniversityCompleted
-
KK Women's and Children's HospitalCompletedPulmonary Aspiration of Gastric ContentsSingapore
-
King Saud UniversityCompletedPulmonary Aspiration of Gastric Contents
-
Uppsala University HospitalRecruitingPulmonary Aspiration of Gastric ContentsSweden
-
Johannes Gutenberg University MainzUniversity Medical Center Freiburg; Krankenhaus der Borromaerinnen Trier; Bundeswehrkrankenhaus... and other collaboratorsCompletedPulmonary Aspiration of Gastric ContentsGermany
-
King Edward Medical UniversityCompletedPulmonary Aspiration of Gastric ContentsPakistan
-
Coombe Women and Infants University HospitalCompletedAspiration; Gastric Contents, AnesthesiaIreland
-
Federal University of Mato GrossoCompletedPulmonary Aspiration of Gastric Contents | Adverse Effects in the Therapeutic Use of Other and Unspecified General Anaesthetics | Pulmonary Aspiration During Anaesthetic InductionBrazil
Clinical Trials on Qualitative and quantitative assessment of gastric content volume with bed elevation
-
SMG-SNU Boramae Medical CenterUnknownPreoperative Fasting
-
Central Hospital, Nancy, FranceUnknown
-
University of Sao Paulo General HospitalRecruitingRespiratory Failure | Pulmonary DiseaseBrazil
-
Johann Wolfgang Goethe University HospitalPalas GmbHRecruitingCovid19 | SARS-CoV-2 InfectionGermany
-
Shanghai Changzheng HospitalUnknownCardiovascular Disease | Lung Neoplasms | Chronic Obstructive Pulmonary Disease | Mass ScreeningChina
-
Ain Shams UniversityCompletedRespiratory Distress Syndrome, NewbornEgypt
-
Memorial Sloan Kettering Cancer CenterCompletedLymphedema | Ovarian Cancer | Vaginal Cancer | Uterine CancerUnited States
-
Northwestern UniversityRecruitingInguinal Hernia Unilateral | Inguinal Hernia BilateralUnited States
-
Vilnius UniversityRecruitingAnalysis of Immunogenicity, Safety and Efficacy of COVID-19 Vaccines in Immunosuppressed IndividualsHematologic Neoplasms | COVID-19 VaccinesLithuania
-
Arbor Research Collaborative for HealthNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Washington... and other collaboratorsActive, not recruiting